Table 2 Combinations of comorbidities and 30-day potentially avoidable readmission
From: Multimorbidity and healthcare resource utilization in Switzerland: a multicentre cohort study
Combinations of comorbidities a | OR (95% CI) | Interaction b | |
|---|---|---|---|
Acute and unspecified renal failure | Solid malignancy | 2.69 (1.81;3.99) | 0 |
Pulmonary heart disease | Solid malignancy | 2.48 (1.70;3.63) | 0 |
Chronic kidney disease | Liver disease | 2.40 (1.60;3.60) | – |
Chronic kidney disease | Solid malignancy | 2.39 (1.79;3.20) | 0 |
Solid malignancy | Chronic obstructive pulmonary disease and bronchiectasis | 2.36 (1.75;3.17) | 0 |
Chronic kidney disease | Chronic obstructive pulmonary disease and bronchiectasis | 2.29 (1.76;2.97) | 0 |
Chronic kidney disease | Other nutritional, endocrine or metabolic disorders | 2.23 (1.41;3.54) | 0 |
Chronic kidney disease | Pulmonary heart disease | 2.15 (1.64;2.83) | 0 |
Esophageal disorders | Solid malignancy | 2.15 (1.39; 3.33) | 0 |
Liver disease | Solid malignancy | 2.13 (1.41; 3.22) | 0 |
Chronic kidney disease | Other and ill-defined heart disease | 2.13 (1.45;3.13) | 0 |
Chronic kidney disease | Other diseases of kidney and ureters | 2.11 (1.41;3.16) | – |
Chronic kidney disease | Thyroid disorders | 2.09 (1.53;2.85) | 0 |
Pulmonary heart disease | Chronic obstructive pulmonary disease and bronchiectasis | 2.06 (1.51;2.80) | 0 |
Chronic kidney disease | Chronic heart disease | 2.02 (1.77;2.30) | 0 |
Chronic heart disease | Systemic lupus erythematosus and connective tissue disorders | 2.01 (1.26;3.21) | 0 |
Paralysis | Other nervous system disorders | 1.98 (1.39;2.82) | + |
Chronic kidney disease | Nephritis, nephrosis, renal sclerosis | 1.95 (1.55;2.47) | 0 |
Epilepsy; convulsions | Solid malignancy | 1.92 (1.25;2.95) | 0 |
Chronic heart disease | Other lower respiratory disease | 1.92 (1.18;3.13) | 0 |